Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS. / Gammelgaard, Bente; Bendahl, L.; Jacobsen, N.W.; Sturup, S.

I: Journal of Analytical Atomic Spectrometry, Bind 20, Nr. 9, 2005, s. 889-893.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gammelgaard, B, Bendahl, L, Jacobsen, NW & Sturup, S 2005, 'Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS', Journal of Analytical Atomic Spectrometry, bind 20, nr. 9, s. 889-893.

APA

Gammelgaard, B., Bendahl, L., Jacobsen, N. W., & Sturup, S. (2005). Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS. Journal of Analytical Atomic Spectrometry, 20(9), 889-893.

Vancouver

Gammelgaard B, Bendahl L, Jacobsen NW, Sturup S. Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS. Journal of Analytical Atomic Spectrometry. 2005;20(9):889-893.

Author

Gammelgaard, Bente ; Bendahl, L. ; Jacobsen, N.W. ; Sturup, S. / Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS. I: Journal of Analytical Atomic Spectrometry. 2005 ; Bind 20, Nr. 9. s. 889-893.

Bibtex

@article{dd751d116fac4296b798fe686e2c2db5,
title = "Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS",
abstract = "Two selenium metabolites, Se-methylseleno-N-acetylgalactosamine (SeGal-N-Ac) and Se-methyl-selenogalactosamine (SeGal-NH2), were quantified in human urine by LC-DRC-ICP-MS. Urine samples were analysed after 1+1 dilution in a reversed phase chromatographic system using an eluent consisting of 200 mM ammonium acetate and 5% methanol with a pH of 9.25 and quantified by standard addition. Samples were collected from 8 volunteers before and after 5 days ingestion of 100 mu g Se day(-1) in form of selenized yeast. The average concentration of (SeGal-NH2) before and after selenium intake was 1.4 and 1.9 mu g Se L-1, respectively, while the average concentration of Se-Gal-N-Ac increased from 2.6 to 11.6 mu g Se L-1 before and after selenium consumption. Detection limits calculated on basis of three times the standard deviation on peak areas of 2 mu g Se L-1 solutions were 0.1 mu g Se L-1 for SeGal-NH2 and 0.2 mu g Se L-1 for SeGal-N-Ac based on peak areas and monitoring Se-80. The precision expressed as the relative standard deviation (n=6) at the 2 mu g Se L-1 level was 3.1 and 1.7% for SeGal-NH2 and SeGal-N-Ac, respectively, while the corresponding values were 1.0 and 0.7% at the 10 mu g Se L-1 level. Linearity in urine matrix was examined in the range 0.5-100 mu g Se L-1 and correlation coefficients better than 0.999 were obtained. As the cationic compound SeGal-NH3+ may be confounded with the trimethylselenonium ion (TMSe+), urine samples were also analysed in a cation exchange chromatographic system in which SeGal-NH3+ was separated from the trimethylselenonium ion. None of the samples contained TMSe+ in detectable amounts. Three sample introduction systems were compared-a microconcentric nebuliser in combination with a cyclonic spray chamber (MCN), a direct injection nebuliser (DIN) and an ultrasonic nebuliser (USN). The MCN was most suitable for this purpose",
author = "Bente Gammelgaard and L. Bendahl and N.W. Jacobsen and S. Sturup",
year = "2005",
language = "English",
volume = "20",
pages = "889--893",
journal = "Journal of Analytical Atomic Spectrometry",
issn = "0267-9477",
publisher = "Royal Society of Chemistry",
number = "9",

}

RIS

TY - JOUR

T1 - Quantitative determination of selenium metabolites in human urine by LC-DRC-ICP-MS

AU - Gammelgaard, Bente

AU - Bendahl, L.

AU - Jacobsen, N.W.

AU - Sturup, S.

PY - 2005

Y1 - 2005

N2 - Two selenium metabolites, Se-methylseleno-N-acetylgalactosamine (SeGal-N-Ac) and Se-methyl-selenogalactosamine (SeGal-NH2), were quantified in human urine by LC-DRC-ICP-MS. Urine samples were analysed after 1+1 dilution in a reversed phase chromatographic system using an eluent consisting of 200 mM ammonium acetate and 5% methanol with a pH of 9.25 and quantified by standard addition. Samples were collected from 8 volunteers before and after 5 days ingestion of 100 mu g Se day(-1) in form of selenized yeast. The average concentration of (SeGal-NH2) before and after selenium intake was 1.4 and 1.9 mu g Se L-1, respectively, while the average concentration of Se-Gal-N-Ac increased from 2.6 to 11.6 mu g Se L-1 before and after selenium consumption. Detection limits calculated on basis of three times the standard deviation on peak areas of 2 mu g Se L-1 solutions were 0.1 mu g Se L-1 for SeGal-NH2 and 0.2 mu g Se L-1 for SeGal-N-Ac based on peak areas and monitoring Se-80. The precision expressed as the relative standard deviation (n=6) at the 2 mu g Se L-1 level was 3.1 and 1.7% for SeGal-NH2 and SeGal-N-Ac, respectively, while the corresponding values were 1.0 and 0.7% at the 10 mu g Se L-1 level. Linearity in urine matrix was examined in the range 0.5-100 mu g Se L-1 and correlation coefficients better than 0.999 were obtained. As the cationic compound SeGal-NH3+ may be confounded with the trimethylselenonium ion (TMSe+), urine samples were also analysed in a cation exchange chromatographic system in which SeGal-NH3+ was separated from the trimethylselenonium ion. None of the samples contained TMSe+ in detectable amounts. Three sample introduction systems were compared-a microconcentric nebuliser in combination with a cyclonic spray chamber (MCN), a direct injection nebuliser (DIN) and an ultrasonic nebuliser (USN). The MCN was most suitable for this purpose

AB - Two selenium metabolites, Se-methylseleno-N-acetylgalactosamine (SeGal-N-Ac) and Se-methyl-selenogalactosamine (SeGal-NH2), were quantified in human urine by LC-DRC-ICP-MS. Urine samples were analysed after 1+1 dilution in a reversed phase chromatographic system using an eluent consisting of 200 mM ammonium acetate and 5% methanol with a pH of 9.25 and quantified by standard addition. Samples were collected from 8 volunteers before and after 5 days ingestion of 100 mu g Se day(-1) in form of selenized yeast. The average concentration of (SeGal-NH2) before and after selenium intake was 1.4 and 1.9 mu g Se L-1, respectively, while the average concentration of Se-Gal-N-Ac increased from 2.6 to 11.6 mu g Se L-1 before and after selenium consumption. Detection limits calculated on basis of three times the standard deviation on peak areas of 2 mu g Se L-1 solutions were 0.1 mu g Se L-1 for SeGal-NH2 and 0.2 mu g Se L-1 for SeGal-N-Ac based on peak areas and monitoring Se-80. The precision expressed as the relative standard deviation (n=6) at the 2 mu g Se L-1 level was 3.1 and 1.7% for SeGal-NH2 and SeGal-N-Ac, respectively, while the corresponding values were 1.0 and 0.7% at the 10 mu g Se L-1 level. Linearity in urine matrix was examined in the range 0.5-100 mu g Se L-1 and correlation coefficients better than 0.999 were obtained. As the cationic compound SeGal-NH3+ may be confounded with the trimethylselenonium ion (TMSe+), urine samples were also analysed in a cation exchange chromatographic system in which SeGal-NH3+ was separated from the trimethylselenonium ion. None of the samples contained TMSe+ in detectable amounts. Three sample introduction systems were compared-a microconcentric nebuliser in combination with a cyclonic spray chamber (MCN), a direct injection nebuliser (DIN) and an ultrasonic nebuliser (USN). The MCN was most suitable for this purpose

M3 - Journal article

VL - 20

SP - 889

EP - 893

JO - Journal of Analytical Atomic Spectrometry

JF - Journal of Analytical Atomic Spectrometry

SN - 0267-9477

IS - 9

ER -

ID: 44288935